Startup, Medical Technology, Innovation, Science.
commercialized his technology through U of T spin-out Interface Biologics Inc. (IBI), which he co-founded in 2001 and where today he serves as chief scientific officer. The next Endexo application is expected to be the plastic hollow fibre membranes used in blood dialysis, which are also prone to